论文部分内容阅读
目的 :探讨经肝动脉介入治疗并发胆囊坏死的发生原因和防治措施。方法 :报告 2例经肝动脉介入治疗并发胆囊坏死的病例 ,均经手术病理证实。并结合文献资料分析这一并发症发生的机率、原因 ,以及为了减少并发症的发生需要注意的一些问题。结果 :近 8年来我院共做经肝动脉介入治疗 6 80例次 ,并发胆囊坏死 2例 (0 3% )。其发生原因是多方面的。超选择插管不到位是该并发症发生的主要原因。结论 :胆囊坏死是经肝动脉介入治疗比较常见的严重并发症之一 ,在今后工作中应引起足够的重视 ,尤其对肝血管瘤的介入治疗更应慎重 ,使这一并发症的发生率降至最低限度。
Objective: To investigate the causes of hepatic artery interventional treatment of gallbladder necrosis and prevention and treatment measures. Methods: 2 cases of hepatic artery interventional treatment of gallbladder necrosis cases were confirmed by surgical pathology. Combined with literature data to analyze the probability of occurrence of this complication, the reasons, as well as some issues that need attention to reduce the incidence of complications. Results: In the past 8 years, our hospital made a total of 680 cases of hepatic artery interventional treatment, complicated by gallbladder necrosis in 2 cases (0 3%). Its causes are many. Superselective intubation is not the main reason for the complications. Conclusions: Gallbladder necrosis is one of the most serious complication of hepatic artery interventional therapy, which should be paid more attention in the future work, especially for the interventional treatment of hepatic hemangioma, so that the incidence of this complication To the minimum.